版本:
中国

BRIEF-Cytosorbents posts safety data from Refresh I cardiac surgery trial

Oct 5 Cytosorbents Corp:

* Announces positive top line safety data from refresh I cardiac surgery trial

* DSMB found no safety concerns related to Cytosorb device, achieving primary safety endpoint Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐